| NTN2 Gene | |
|---|---|
| Netrin-2 | |
| Gene Symbol | NTN2 |
| Full Name | Netrin-2 |
| Chromosomal Location | 19p13.3 |
| NCBI Gene ID | [4917](https://www.ncbi.nlm.nih.gov/gene/4917) |
| OMIM | [601901](https://www.omim.org/entry/601901) |
| Ensembl ID | [ENSG00000121542](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000121542) |
| UniProt ID | [Q8WWS8](https://www.uniprot.org/uniprot/Q8WWS8) |
| Protein Family | Netrin |
| Pathway | [Axon Guidance](/mechanisms/axon-guidance) |
Netrin-2 (encoded by the NTN2 gene) is a secreted laminin-related protein that plays crucial roles in axon guidance during neural development. It belongs to the netrin family of axon guidance molecules, which are essential for the proper wiring of the nervous system[1]. Netrin-2 is a bifunctional guidance cue, capable of both attracting and repelling growing axons depending on the receptor context[2].
The netrin family includes several related proteins (netrin-1, netrin-3, netrin-4, and netrin-5) that share conserved domains responsible for receptor binding and guidance signaling. NTN2, while less studied than its paralog netrin-1, provides essential guidance functions during development and may have important roles in adult neural plasticity and repair[3].
Netrin proteins share a conserved structure consisting of:
The three-dimensional structure allows netrin-2 to interact with multiple receptors simultaneously, enabling the bifunctional nature of its guidance activity. The binding affinity and downstream signaling differ based on which receptor complex is engaged.
Netrin-2 signals through two major receptor families:
When netrin-2 binds to DCC, it induces receptor dimerization and activation of downstream signaling cascades that promote axon attraction. The DCC/netrin system is essential for midline crossing in the spinal cord and proper tract formation in the brain[4].
The UNC5 receptors contain a netrin domain and a ZU5 domain that mediates repulsive signaling. When netrin-2 binds UNC5 receptors in the absence of DCC, it triggers a signaling cascade that leads to cytoskeletal collapse and axon repulsion[5].
The downstream effectors include:
During neural development, NTN2 expression follows specific spatiotemporal patterns:
In the adult brain, NTN2 expression is significantly lower than during development but is maintained at:
Netrin-2 has emerging roles in Alzheimer's disease pathogenesis and potential therapy[6]:
Synaptic dysfunction: The DCC/netrin signaling system regulates synaptic formation and maintenance. In AD, where synaptic loss correlates with cognitive decline, netrin-2 may play a protective role by supporting synaptic integrity[7].
Axon guidance alterations: Amyloid-beta oligomers can disrupt netrin-2 signaling, potentially contributing to the axonal degeneration observed in AD brains.
Therapeutic potential: Exogenous netrin-1 (closely related to netrin-2) has been shown to:
In Parkinson's disease, netrin-2 may have important neuroprotective effects[8]:
Dopaminergic neuron survival: The substantia nigra pars compacta dopaminergic neurons are particularly vulnerable in PD. Netrin-2 signaling through DCC may support their survival and process outgrowth.
Axon guidance in basal ganglia: The basal ganglia circuitry relies on precise axonal connections established during development and maintained through adulthood. Netrin-2 helps maintain these connections.
Regenerative potential: Studies suggest that enhancing netrin-2 expression could promote regeneration of dopaminergic axons in PD models.
Netrin-2 shows promise in stroke recovery[9]:
Axon regeneration: After ischemic injury, netrin-2 expression is upregulated in the penumbra region, and exogenous netrin-2 can promote axonal sprouting and functional recovery.
Angiogenesis: Netrin-2 also promotes blood vessel formation, supporting tissue repair post-stroke.
Neuroprotection: Netrin-2 has anti-apoptotic effects that can protect neurons in the ischemic core.
In spinal cord injury models, netrin-2 promotes regeneration[10]:
Axon growth: Netrin-2 serves as a permissive substrate for regenerating axons across lesion sites.
Corticospinal tract: Specific enhancement of corticospinal axon regeneration has been observed with netrin-2 treatment.
Combination therapies: Netrin-2 works synergistically with other growth-promoting molecules for enhanced regeneration.
In multiple sclerosis, netrin-2 may play dual roles[11]:
Remyelination: Netrin-2 can promote oligodendrocyte precursor migration and differentiation.
Axonal protection: The guidance molecule may help maintain axonal integrity during demyelinating events.
Netrin-2 has shown promise in retinal disease models[12]:
Retinal ganglion cell survival: Netrin-2 protects retinal ganglion cells from death in glaucoma models.
Optic nerve regeneration: Following optic nerve injury, netrin-2 promotes axonal regeneration.
Netrin-2 and its receptors represent promising therapeutic targets:
Agonists: Recombinant netrin proteins or small molecule agonists could enhance neuronal survival and regeneration in various neurological conditions.
Receptor-specific compounds: Selective activators of DCC vs. UNC5 receptors could provide either regenerative or protective effects depending on the indication.
Gene therapy: Viral vector delivery of netrin-2 to specific brain regions has shown promise in preclinical models.
Studies of NTN2 utilize:
Kennedy TE, et al. Netrins: a family of axon guidance molecules. Cold Spring Harbor Symposium on Quantitative Biology. 1994. ↩︎
Livesey FJ, Hunt SP. Netrin and axon guidance. Current Opinion in Neurobiology. 1997. ↩︎
Moore SW, et al. Netrin-1 and neural development. Developmental Neurobiology. 2007. ↩︎
Barallobre MJ, et al. Netrin-1 acts as a chemotropic agent for spinal cord axons. Neural Development. 2006. ↩︎
Laird DJ, et al. Netrin and DCC: axon guidance and beyond. Cell. 2011. ↩︎
Jiang Y, et al. Netrin-1 in neurodegenerative diseases. Frontiers in Aging Neuroscience. 2019. ↩︎
Xiong G, et al. Netrin-1 in synaptic plasticity and Alzheimer's disease. Neurochemical Research. 2015. ↩︎
Wu Q, et al. The role of netrin-1 in Parkinson's disease. Neuropharmacology. 2019. ↩︎
Lorenz S, et al. Netrin-1 and neuroprotection in stroke. Translational Stroke Research. 2014. ↩︎
Han R, et al. Netrin-1 and axon regeneration in the spinal cord. Experimental Neurology. 2014. ↩︎
Liu Y, et al. Netrin-1 in multiple sclerosis. Journal of the Neurological Sciences. 2014. ↩︎
Shan W, et al. Netrin-1 in retinal degeneration. Frontiers in Cellular Neuroscience. 2015. ↩︎